Top Markets
Coin of the day
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Classificação em ações #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Preço da ação
$9.81
Última sincronização: 2025-03-18
Valor de mercado
$48.68M
Variação (1 dia)
1.55%
Variação (1 ano)
0.00%
País
US
Negociar AlloVir, Inc. (ALVR)

Categoria

EPS de AlloVir, Inc. (ALVR)
EPS em June 2026 TTM: $-1.71
De acordo com os últimos relatórios financeiros e o preço das ações da AlloVir, Inc., o EPS atual da empresa (TTM) é $-1.71. No final de 2023, a empresa teve um EPS de $-42.09, uma diminuição em relação a ao EPS de 2022, que foi de $-50.60.
Histórico de EPS da AlloVir, Inc. de 2018 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-1.71 -85.42%
2024 $-11.73 -72.13%
2023 $-42.09 -16.82%
2022 $-50.60 -19.71%
2021 $-63.02 5.79%
2020 $-59.57 354.39%
2019 $-13.11 71,150.00%
2018 $-0.02 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -1,112.87%
US
$27.74 -1,722.22%
NL
$2.98 -274.27%
AU
- -
CH
$-7.98 366.67%
US